We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You must tell DVLA if you have multiple sclerosis - download the correct form to let them know
This document contains a synopsis of causation occurring in Multiple Sclerosis.
Analysis of a sample of primary care records relating to diagnosed cases of multiple sclerosis in England.
This document contains a synopsis of causation occurring in Polymyositis, Dermatomyositis, Systemic Sclerosis & Systemic Vasculitis.
You must tell DVLA if you have motor neurone disease - also known as amyotrophic lateral sclerosis (ALS) - download the correct form to let them know
Explains how commissioners and health professionals can use data and analysis for decisions about neurology services and interventions.
Report certain types of medical conditions to DVLA if you're a car driver or motorcyclist.
You’re disabled under the Equality Act 2010 if you have a physical or mental impairment that has a 'substantial' and 'long-term' negative effect on your ability to do daily activities
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Healthcare professionals should report any suspected adverse effects relating to fingolimod (Gilenya▼) or other treatments for multiple sclerosis, including suspected adverse effects occurring after discontinuation, via the Yellow Card Scheme.
Projects granted during 2016 that have a primary purpose of basic research, nervous system.
The purpose of this leaflet is to give an update on progress with the Risk Sharing Scheme for Disease Modifying Therapies (DMTs) in Multiple Sclerosis.
Report certain types of medical conditions to DVLA if you're a lorry, bus or coach driver.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Patricia Gordon had a career in the Health and Social Care sector in Northern Ireland where she worked in strategic planning, information and general management roles. Patricia was CEO of the Mater Hospital Trust from 1995-2003 and CEO of the...
This letter from Claire Potter Medicines, Pharmacy & Industry Group and Jackie Palace, Clinical Advisor for MS Risk Sharing Scheme, provides information about the risk sharing scheme and the legal obligation for compliance within the NHS.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.